News | September 02, 2023
Biocon acquires oral solid dosage manufacturing facility of Eywa Pharma for US$7.7 million
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The approval bolsters the company's Mycophenolate Mofetil portfolio
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
Subscribe To Our Newsletter & Stay Updated
